Kronik Güçsüz Çocuğa Yaklaşım
Özet
Kronik güçsüzlük, çocuklarda sekiz haftadan uzun süren kas zayıflığı olarak tanımlanır ve kesin tanı için detaylı bir öykü ile nörolojik muayene şarttır. Tanısal yaklaşım, güçsüzlüğün anatomik yerleşimini belirleyerek üst veya alt motor nöron kaynaklı olduğunu saptamaya dayanır; bu süreçte görüntüleme, genetik testler ve biyopsi gibi yöntemler kullanılır. Tedavi planı; serebral palsi, nörodejeneratif bozukluklar veya çeşitli kas hastalıkları gibi altta yatan spesifik nedene yönelik olarak multidisipliner şekilde oluşturulmalıdır.
Chronic weakness in children is defined as muscle impairment persisting for more than eight weeks, necessitating a comprehensive medical history and neurological examination. The diagnostic approach relies on pinpointing the anatomical site—whether upper or lower motor neuron—through laboratory tests, neuroimaging, and genetic analysis. Effective management requires a multidisciplinary strategy tailored to specific underlying etiologies, such as cerebral palsy, muscular dystrophies, or spinal muscular atrophy.
Referanslar
Pina-Garza JE, James KC. Flaccid Limb Weakness in Childhood. In: Fenichel’s Clinical Pediatric Neurology. 8th Edition. Elsevier, Philedelphia, USA; 2019. p.172-197.
Medical Research Council. Aids to the examination of the peripheral nervous system. London: Her Majesty’s Stationery Office; 1981.
Sparks SE. Neonatal hypotonia. Clin Perinatol. 2015 Jun;42(2):363-371.
Diseases of the Motor Unit. In: Menkes JH, Sarnat HB, eds. Child Neurolgy 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2000.
Migita R. Etiology and evaluation of the child with weakness. In Wiley JF, editor. Uptodate. 2019 Oct 08. (05.06.2021).
Oskoui M, Coutinho F, Dykeman J, et al. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol. 2013 Jun;55(6):509-519.
Ashwal S, Russman BS, Blasco PA, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2004 Mar 23;62(6):851-863.
Surveillance of Cerebral Palsy in Europe. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol. 2000 Dec;42:816-824.
Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer. 2008;112:416-432.
Brooks BR, Antel J, Bradley WG. El Escorial World Federation of Neurology Criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994 Jul;124 Suppl:96-107.
Mastrangelo M. Clinical approach to neurodegenerative disorders in childhood: an updated overview. Acta Neurol Belg. 2019 Dec;119(4):511-521.
Soonawala N, Overweg-Plandsoen WC, Brouwer OF. Early clinical signs and symptoms in occult spinal dysraphism: a retrospective case study of 47 patients. Clin Neurol Neurosurg. 1999;101:11-14.
Sarnat HB. Disorders of segmentation of the neural tube: Chiari malformations. Handb Clin Neurol. 2008;87:89-103.
Bodamer OA. Spinal muscular atrophy. In Dashe JF, editor. Uptodate. 2021 Apr 16. (07.06.2021).
Liedholm LJ, Eeg-Olofsson O, Ekenberg BE, Nicolaysen RB, Torbergsen T. Acute postasthmatic amyotrophy (Hopkins' syndrome). Muscle Nerve. 1994;17:769-772.
Executive summary: Neonatal brachial plexus palsy. Report of the American College of Obstetricians and Gynecologists' Task Force on Neonatal Brachial Plexus Palsy. Obstet Gynecol. 2014 Apr;123:902-904.
Bodamer OA. Overview of peripheral nerve and muscle disorders causing hypotonia in the newborn. In Goddeau RP, editor. Uptodate. 2019 Jul 30. (10.06.2021).
Andrews PI, Massey JM, Howard JF Jr, Sanders DB. Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis. Neurology 1994;44(7):1208.
North KN. Clinical approach to the diagnosis of congenital myopathies. Semin Pediatr Neurol. 2011;18(4):216-220.
Tzeng AC, Bach JR. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest. 2000;118(5):1390-1396.
Lanni S, Pearson CE. Molecular genetics of congenital myotonic dystrophy. Neurobiol Dis. 2019 Dec;132:104533.
Gianni M, Callen JP. Treatment of dermatomyositis with methotrexate and prednisone. Arch Dermatol. 1979;115:1251-1252.
Bunim JJ, Ziff M, McEwen C. Evaluation of prolonged cortisone therapy in rheumatiod arthritis: A four-year study. Am J Med. 1955;18:27-40.
Finsterer J, Stollberger C, Grossegger C, Kroiss A. Hypothyroid myopathy with unusually high serum creatine kinase values. Hormone Res. 1999;52(4):205-208.
